APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -73.4% | +13.3% | +425.8% | +97.0% | +28.5% | |
| – | – | – | – | – | +152.0% | -99.5% | +4,106.9% | -79.2% | +8.4% | +938.1% | +101.2% | -13.2% | |
| – | – | – | – | – | – | – | – | -72.8% | +13.7% | +384.5% | +96.3% | +35.8% | |
| – | +261.7% | +63.8% | +67.4% | +75.4% | +161.2% | +109.9% | +35.7% | +40.3% | -8.0% | -8.5% | -7.6% | -9.7% | |
| – | +70.5% | +118.6% | -32.3% | +143.1% | +116.4% | +196.2% | +107.9% | +26.8% | +56.8% | +80.7% | -16.6% | +31.7% | |
| – | +180.2% | +77.9% | +35.8% | +86.1% | +152.0% | +124.7% | +52.9% | +36.0% | +11.2% | +28.7% | -3.1% | +2.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +2,493.0% | +110.3% | +466.5% | -55.8% | +146.4% | -9.3% | +36.5% | +9.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -312.7% | – | -63.9% | -80.9% | +90.1% | +218.7% | -45.5% | +48.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -526.4% | – | – | – | – | – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.